Hi Lectro, thanks for that. I dont have a problem with any of...

First 4 Last

Share
Profile

Follow
Names little

17,847 Posts.

1251

10/02/21

17:32

Post #: 50870191
Share

Originally posted by lectro ↑

My understanding is the majority of placement has gone to a couple of major institutional investors that the company had been talking to for months. I think they were caught a little off guard by how quick the red rate has come , particularly in the last week. I believe it was a matter of act now , at this price or they may have missed the boat for this amount of funds.
Government funding is still in place , however waiting for this to happen whilst the opportunity to raise funds at this price needed to be taken into account.
There may be a breather in price appreciation for a couple of days, but upon reflection how can we look at this negatively, especially as a long term long.It is in fact the very scenario that many of us have been debating for months as the debt funding dragged out. We now have the first spherical graphite plant outside of China fully funded , pending debt portion , (which in my opinion is a given), a recycling pilot plant funded and being built as we speak and sufficient funds to bring Epanko online once the TZ government get there shite together. As was previously mentioned, only one month ago if we were presented with this opportunity and stock price we would have jumped at it and been bowled over by it.
I don’t know whether we will still get the impact from the Kwinana debt funding announcement that we all were expecting in 2 months but why wouldn’t this CR present the same positive outcome. It is equity not debt after all. It is now known how much our equity portion is and the project is a goer. It’s all good.
For all the traders or recent purchasers who are screaming atm , I empathise but don’t really feel sorry. Most long termers here have stuck with Knl /EGR for more than 7 years and been through all of the downside for most of that. The fact that your trade may have been messed up because management has done what in their view was best for the company going forward ,whilst unfortunate is not a death nell. If you saw value at $1 , surely you see the same value at anything under that. Personally I think this was desperately needed before any listing in the states and will only strengthen the companies fundamentals when listing there. It may have even been a requirement to have a level of capital before listing on the top tier exchange.
Fundamentally nothing has changed in the business plan , except the order in which it has occurred.
Looking forward to:
Kwinana debt funding announcement
Binding off take notification
Epanko debt financing approval
Recycling pilot plant commissioning and results
Strategic partner announcement ( yes still on the table)
For our fellow holders in Germany, don’t forget the bigger picture and where this is headed. This may be the infusion that is needed to send us through to the next level and hey, we won’t be having to listen to any mobs telling us that a CR is overdue , it’s only a matter of time, this is just a pump prior to a CR. It is done and dusted and nothing us plebs can do but sit back and enjoy.
Why would anybody sell at the CR levels or even under $1 because of this? It has only made the company and our money safer and much stronger. The German market maker may benefit though if any Sophs sell but I believe most funds were raised with major instos who are in for the long haul and dividend stream that’s to come.
Donrt worry be happy.
All in my humble opinion.
PS. By the way, I have a stack of these shares and have not sold one. There is too much value that hasn’t been unlocked IMO.

Expand

Hi Lectro, thanks for that. I dont have a problem with any of that. It was my initial thought that SP may have been getting away from potential strategic investors.

Just i dont see why if its good enough for them to get such a big discount from current price then why not good enough for retail to add another $5 to $10m.

EGR Price at posting: $1.00 Sentiment: None Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Failure to report prompts ASX to impose multiple company suspensions

IRE

Iress runs 'hot' for Wealth Within's stock tips

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 24 more messages in this thread...

First 4 Last

Add EGR (ASX) to my watchlist

(20min delay)
Last 9.5¢		Change 0.003(3.26%)		Mkt cap ! $43.13M

Open	High	Low	Value	Volume
9.1¢	9.5¢	8.9¢	$25.99K	279.2K

Buyers (Bids)

No.	Vol.	Price($)
1	3968	8.9¢

Sellers (Offers)

Price($)	Vol.	No.
9.5¢	25000	1

View Market Depth

No.	Vol.	Price($)
1	3968	0.089
3	117386	0.088
2	19505	0.087
2	88000	0.086
1	10000	0.085

Price($)	Vol.	No.
0.095	25000	1
0.097	18000	2
0.098	8000	1
0.099	100000	2
0.100	829704	4

Last trade - 16.10pm 01/10/2024 (20 minute delay)

EGR (ASX) Chart

Hi Lectro, thanks for that. I dont have a problem with any of...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Failure to report prompts ASX to impose multiple company suspensions

Iress runs 'hot' for Wealth Within's stock tips

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi Lectro, thanks for that. I dont have a problem with any of...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Failure to report prompts ASX to impose multiple company suspensions

Iress runs 'hot' for Wealth Within's stock tips

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News